Key Points for Investors

• Board Meeting Date: The Board will meet on 20 March 2026.
• Purpose: The primary agenda is to consider and approve the audited financial results for the year ended 31 December 2025. This is a crucial event as the release of annual audited results often has a significant impact on investor sentiment and share price.
• Additional Business: The Board may also transact other business, should any arise.
• Board Composition: The current Board consists of five executive directors—Mr. Li Xiaojun, Mr. Chen Jiehui, Mr. Cheng Hongjin, Mr. Tang Heping, and Mr. Li Hong—and four independent non-executive directors—Mr. Chen Yajin, Mr. Huang Min, Mr. Wong Lung Tak Patrick, and Ms. Sun Baoqing.

Potential Price-Sensitive Information

• Financial Results Announcement: The upcoming disclosure of audited annual results is a potentially price-sensitive event. Investors and shareholders should closely monitor this, as the financial performance for the year 2025 will impact market perception and share valuation.
• Possible Additional Resolutions: While the main agenda is the financial results, the Board may discuss other matters that could be material to shareholders.

Implications for Shareholders

Shareholders should pay particular attention to the outcome of this Board meeting, as the release of the audited financials could influence the company’s share price. Any unexpected results—positive or negative—may lead to significant price movements. The Board may also address other corporate matters during the meeting, so investors should stay alert for any further announcements.

Next Steps

Investors are advised to mark 20 March 2026 in their calendars and await the official publication of the audited results. Further announcements will be made by the company as appropriate, and shareholders should review all details closely upon release.

Disclaimer: The information above is based on the latest announcement by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. This article does not constitute investment advice. Investors should conduct their own analysis and consult professional advisors before making investment decisions.

View BAIYUNSHAN PH Historical chart here